Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-02

Clinical Trial Update: Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating comparison of hepatic hilar nerve block versus sham for pain control during liver ablation and transarterial chemoembolization (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • hepatic hilar nerve block

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Pain Control, Liver Cancer | Phase 4 | Status: UNKNOWN